Skip to content. | Skip to navigation

Agenus acquires from Diatheva s.r.l., an Italian biothech company controlled by SOL S.p.A., novel antibodies to Immuno-oncology Target CEACAM1

Search results

RSS Subscribe to an always-updated RSS feed.

0 items matching your search terms. Sort by relevance · date (newest first) · alphabetically

No results were found.